16 results on '"Fukami, Kei"'
Search Results
2. New Estimation Formulas for Daily Sodium Intake in Hemodialysis Patients by a Duplicate Portion Method
3. Serum albumin-adjusted glycated albumin reflects glycemic excursion in diabetic patients with severe chronic kidney disease not treated with dialysis
4. Dipeptidyl peptidase-4 deficiency protects against experimental diabetic nephropathy partly by blocking the advanced glycation end products-receptor axis
5. Glucagon-Like Peptide-1 Receptor Agonist Inhibits Asymmetric Dimethylarginine Generation in the Kidney of Streptozotocin-Induced Diabetic Rats by Blocking Advanced Glycation End Product–Induced Protein Arginine Methyltranferase-1 Expression
6. Proteinuria elevates asymmetric dimethylarginine levels via protein arginine methyltransferase-1 overexpression in a rat model of nephrotic syndrome
7. WCN24-1846 Linagliptin increases urinary sodium excretion via deactivating renal ENaC in diabetic rodents and patients with diabetes mellites
8. WCN24-1847 Characterization of regulatory B cells and IL-10 in response to ischemic reperfusion
9. Positive association of serum levels of advanced glycation end products and high mobility group box–1 with asymmetric dimethylarginine in nondiabetic chronic kidney disease patients
10. Involvement of asymmetric dimethylarginine (ADMA) in glomerular capillary loss and sclerosis in a rat model of chronic kidney disease (CKD)
11. Advanced glycation end products evoke inflammatory reactions in proximal tubular cells via autocrine production of dipeptidyl peptidase-4
12. Chapter 10 - An Overview on Diabetic Nephropathy
13. List of Contributors
14. Corrigendum to “Telmisartan inhibits AGE-induced podocyte damage and detachment” [Microvascular Research 88 (2013) 79–83]
15. Chapter 12 - An Overview of Diabetic Nephropathy
16. Contributors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.